Skip to main content
The Lancet Regional Health - Europe logoLink to The Lancet Regional Health - Europe
. 2024 Nov 16;47:101132. doi: 10.1016/j.lanepe.2024.101132

Corrigendum to “Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands” [The Lancet Regional Health—Europe, Volume 42, July 2024, 100927]

Jakob L Schroevers a,, Marieke P Hoevenaar-Blom a,b, Wim B Busschers a, Monika Hollander c, Willem A Van Gool b, Edo Richard b,d, Jan Willem Van Dalen d,e,f, Eric P Moll van Charante a,b,f
PMCID: PMC11614856  PMID: 39633892

The authors have identified an error in the introduction of the main text. The correct statement should read: “Hypertension is an important risk factor for all-cause dementia, including Alzheimer’s disease (AD). It affects over 70% of adults aged 60 and older,” rather than “Hypertension is an important risk factor for all-cause dementia, including Alzheimer’s disease (AD), which is the cause of dementia in over 70% of adults aged 60 and older.”

This correction pertains solely to the background information of this paper and does not impact the study's results or interpretations in any way. We apologize for any confusion this may have caused and are available to address any questions or comments.

Contributor Information

Jakob L. Schroevers, Email: j.schroevers@amsterdamumc.nl.

Marieke P. Hoevenaar-Blom, Email: m.p.hoevenaarblom@amsterdamumc.nl.

Wim B. Busschers, Email: w.b.busschers@amsterdamumc.nl.

Monika Hollander, Email: m.hollander-2@umcutrecht.nl.

Willem A. Van Gool, Email: w.a.vangool@amsterdamumc.nl.

Edo Richard, Email: edo.richard@radboudumc.nl.

Jan Willem Van Dalen, Email: janwillem.vandalen@radboudumc.nl.

Eric P. Moll van Charante, Email: e.p.mollvancharante@amsterdamumc.nl.


Articles from The Lancet Regional Health - Europe are provided here courtesy of Elsevier

RESOURCES